Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D

BACKGROUND: The systemic inflammation is associated with clinical outcome and mortality in chronic obstructive pulmonary disease (COPD) patients. To investigate the effects of tiotropium (Tio) and/or budesonide/formoterol (Bud/Form) on systemic inflammation biomarkers in stable COPD patients of grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Hua, Liao, Xi-Ning, Fan, Li-Li, Qu, Yue-Jin, Cheng, De-Yun, Shi, Yong-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568104/
https://www.ncbi.nlm.nih.gov/pubmed/28832630
http://dx.doi.org/10.1371/journal.pone.0183300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568104/
https://www.ncbi.nlm.nih.gov/pubmed/28832630
http://dx.doi.org/10.1371/journal.pone.0183300

Ejemplares similares